FourKites Launches Universal Time Slot Solution in Europe to Ease Supply Chain Labor Shortage Woes and Reduce Greenhouse Gas Emissions
6.4.2022 11:36:00 EEST | Business Wire | Press release
FourKites ®, the #1 real-time supply chain visibility platform, today launches Slot Manager, its universal time slot booking solution, across Europe. The cloud-based solution helps warehouses, distribution centers and manufacturing facilities collaborate efficiently on pickup and receiving time slots, saving significant time and improving daily operations and partner relationships. In addition, the highly configurable solution allows shippers and carriers to eliminate excess dwell time on site, eliminating detention fees and significantly reducing carbon emissions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220406005544/en/
FourKites today launches Slot Manager, its universal time slot booking solution, across Europe. (Photo: Business Wire)
Time slot management is a notoriously time-consuming task for shippers and carriers alike. With carrier dwell averaging up to 4.35 hours per day, or nearly half of a driver’s time, Slot Manager improves facility productivity and reduces carrier wait time by more than 50%. Highly configurable for personalised requirements, Slot Manager enables shippers and carriers to collaborate in real time, and allows carriers to self-book their preferred time slot based on real-time transit conditions, thereby eliminating hours of daily administrative work and error-prone manual processes.
Slot Manager is an extension of FourKites’ Appointment ManagerSM, launched over two years ago. The solution is now also available in several new Asia-Pacific markets, including Australia, New Zealand and India.
Specifically, Slot Manager offers the following benefits:
- Labor optimisation: Leveraging FourKites’ Dynamic ETA® to provide the most accurate times of arrival, teams can better allocate labor and resources based on real-time data and shifts in expected arrival time.
- Ease and compliance with carrier scheduling: Slot Manager creates a single appointment layer accessible to both shippers and carriers to streamline communication and facilitate collaboration. Slots are created by the facility to ensure adherence to preferred scheduling, business rules and specific commodity requirements.
- True end-to-end visibility: Powered by real-time supply chain visibility data from FourKites, Slot Manager extends visibility even further into the facility via one streamlined interface. With FourKites, stakeholders receive a comprehensive end-to-end view of shipments from point of origin to predictive insights that help orchestrate activities in the facility.
- Diminished carrier detention costs: With optimised scheduling, carrier dwell on site can be virtually eliminated, helping shippers avoid detention fees and fines for truck queues on public roads.
- Reduced carbon emissions: Scheduling and operational efficiencies driven by Slot Manager reduce time carriers spend in the yard by up to 50%, cutting carbon dioxide emissions by an average of 54%.
“We are excited to introduce the easiest, most flexible slot booking application on the market,” said Mathew Elenjickal, FourKites Founder and CEO. “This groundbreaking solution helps shippers across the globe optimise end-to-end visibility, efficiency and sustainability, as well as adapt quickly as their business needs change. We’re thrilled to be launching Slot Manager in Europe, specifically tailored to the needs of local facilities.”
In addition, FourKites has partnered with French transportation solutions firm IER, a Blue Systems entity (Bolloré Group), to facilitate integrated implementation in Europe, driving greater efficiency for both carriers and facilities. The partnership combines IER’s leading standard of facility hardware technology with facility processes for automated check-in and check-out. When combined with FourKites’ advanced data capture and processing capabilities, the companies’ combined pre-configured integration offers a fast, turnkey facility solution for customers.
"We chose to partner with FourKites due to their globally recognised data quality and their commitment to delivering that data back to customers with actionable insights," said Christophe Levy, Chief Executive Officer of IER’s Track & Trace Unit. "By combining FourKites’ advanced supply chain intelligence capabilities with our leading facility hardware capabilities, we offer a seamlessly integrated solution that helps customers achieve immediate results for their business."
About FourKites
FourKites® is the #1 supply chain visibility platform in the world, extending visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.5 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching more than 185 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,000 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220406005544/en/
Contact information
Scott Johnston | FourKites European PR Director | scott.johnston@fourkites.com | +31 62 147 8442
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release
Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
